Literature DB >> 24632952

NLRP3 inflammasome as a novel player in myocardial infarction.

Masafumi Takahashi1.   

Abstract

Inflammasomes are multiple protein complexes that serve as molecular platforms to activate caspase-1 and regulate maturation of a potent proinflammatory cytokine, interleukin (IL)-1β, as well as proinflammatory cell death, pyroptosis. Although several types of inflammasomes have been reported so far, recent investigations indicate that the NLRP3 inflammasome recognizes non-microbial danger signals and leads to sterile inflammatory responses in various disease conditions. Sterile inflammatory responses are also implicated in the development of myocardial infarction (MI). In particular, IL-1β is an early and prominent mediator of inflammatory responses in MI, suggesting the pathophysiologic role of NLRP3 inflammasomes in MI. This review highlights the current state of knowledge regarding the role of NLRP3 inflammasomes in MI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632952     DOI: 10.1536/ihj.13-388

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  71 in total

Review 1.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Ochratoxin A induces nephrotoxicity in vitro and in vivo via pyroptosis.

Authors:  Hu Li; Xinru Mao; Kai Liu; Jiahao Sun; Benrui Li; Rahmani Mohammad Malyar; Dandan Liu; Cuiling Pan; Fang Gan; Yunhuan Liu; Kehe Huang; Xingxiang Chen
Journal:  Arch Toxicol       Date:  2021-02-04       Impact factor: 5.153

3.  A Polymorphism Within the 3'UTR of NLRP3 is Associated with Susceptibility for Ischemic Stroke in Chinese Population.

Authors:  Zhansheng Zhu; Jing Yan; Chunsong Geng; Dagang Wang; Chaoyang Li; Shuai Feng; Huiping Wang
Journal:  Cell Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.046

4.  Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway.

Authors:  Yang-Shuo Tang; Yan-Hua Zhao; Yong Zhong; Xiao-Zhao Li; Jia-Xi Pu; Yan-Cheng Luo; Qiao-Ling Zhou
Journal:  Inflamm Res       Date:  2019-06-06       Impact factor: 4.575

5.  Elevated hydrostatic pressure stimulates ATP release which mediates activation of the NLRP3 inflammasome via P2X4 in rat urothelial cells.

Authors:  Cody L Dunton; J Todd Purves; Francis M Hughes; Huixia Jin; Jiro Nagatomi
Journal:  Int Urol Nephrol       Date:  2018-08-11       Impact factor: 2.370

Review 6.  The NLRP3 inflammasome in acute myocardial infarction.

Authors:  Stefano Toldo; Antonio Abbate
Journal:  Nat Rev Cardiol       Date:  2017-11-16       Impact factor: 32.419

7.  Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.

Authors:  Yana Wang; Jiali Liu; Qiuyue Kong; Hao Cheng; Fei Tu; Peng Yu; Ying Liu; Xiaojin Zhang; Chuanfu Li; Yuehua Li; Xinxu Min; Shuya Du; Zhengnian Ding; Li Liu
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

8.  Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Matthew D McGeough; Carla A Peña; Carlo Marchetti; Chiara Sonnino; Benjamin W Van Tassell; Fadi N Salloum; Norbert F Voelkel; Hal M Hoffman; Antonio Abbate
Journal:  Cardiovasc Res       Date:  2014-12-18       Impact factor: 10.787

Review 9.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

Review 10.  Monocyte recruitment and fate specification after myocardial infarction.

Authors:  Kyle I Mentkowski; Lindsey M Euscher; Akshar Patel; B Rita Alevriadou; Jennifer K Lang
Journal:  Am J Physiol Cell Physiol       Date:  2020-09-02       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.